Cannon Global Investment Management, LLC
Position in ALNY — Alnylam Pharmaceuticals, Inc.
CIK 1844427
DAVIE, FL
Position in ALNY
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$752,575
-$41,513 QoQ
Shares Held
2,500
+4.2% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
2.38%
of 13F equity value
Holder Rank
#437
of 785 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Cannon Global Investment Management, LLC holds $3,747,880 across 6 Biotechnology names. ALNY ranks #2 (20.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
1,500 | $805,425 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
2,500 | $752,575 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
4,000 | $749,120 | |
| 4 | ABVX |
Abivax S.A.
|
5,300 | $706,278 | |
| 5 | INBX |
Inhibrx Biosciences, Inc.
|
5,900 | $559,025 | |
| 6 | TBPH |
Theravance Biopharma, Inc.
|
10,321 | $175,457 |
All Filings in ALNY
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $752,575 | 2,500 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $794,088 | 2,400 | Shares | Sole | 2026-04-21 | |
| No filing history on record for this holder in this stock. | ||||||